Real estate companies have been known to expand outside of the industry to dip their toes into other endeavors.
Adevinta has done just that. The Adevinate Ventures team is investing in MEDWING for a second time. MEDWING, one of the leading healthtech companies in Europe, is running a series B funding round, led by Cathay Innovation with participation from Northzone, Atlantic Labs, and Cherry Ventures. MEDWING looks to raise €28 million in this round.
MEDWING will use the funding to support innovation and develop new features, products, and offer new services for the healthcare industry. The capital will also go towards expanding its international business and team.
Ovidiu Solomonov, VP Global Markets, and Ventures at Adevinta, says:
“Medwing gives power, autonomy, and transparency to nurses, addressing some of the inefficiencies in the healthcare staffing industry. Medwing perfectly illustrates our view that digital marketplaces can help to unlock supply in sectors which are not yet fully online. This is why we chose to double-down on our investment in Medwing through their series B.”
Adevinta is a digital marketplace giant in Europe, focused on digitizing the entire buying and selling process. Helping another company outside of its focused industry to digitize further spreads its goal that the future is tech.